Trial Profile
Phase I/II trial of KRN7000 in patients with chronic hepatitis C infection
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Alpha galactosylceramide (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 14 Oct 2006 New trial record.